Oslo, 18 March 2021:

Following vesting and exercise of previously issued employee options, the Board
of Directors of Pexip Holding ASA ("Pexip" or the "Company", Oslo Børs ticker
"PEXIP") has resolved, based on authorisation granted by the Company's general
meeting held on 20 March 2020, to issue 2,253,896 new shares for an aggregate
subscription price of NOK 72,320,810. The shares have been subscribed for by
various employee option holders.

The Company has also in cooperation with ABG Sundal Collier ASA, Carnegie AS and
Pareto Securities AS ("the IPO syndicate") facilitated a transaction to allow
the exercising option holders to sell parts of their shares following exercise,
to cover the strike amount and tax as well as a sell-down of maximum 15% of
their holdings.

The shares are sold to a single institutional investor at NOK 100.00 per share.

"Through this transaction, Pexip is strengthening its shareholder base with a
leading long-term institutional investor. Following a period of strong
operational performance, reinforced market trends related to remote and hybrid
work environments, as well as accelerated financial performance, we have seen
increased interest around the Pexip share. Hence, the Board has decided to
facilitate the exercise of options and a limited share sale for management and
early-stage investors at this point in time. The selling shareholders continue
to support Pexip, keeping the vast majority of their holdings," says Michel
Sagen, Chair of the Board and co-founder of Pexip.

In connection with the above, the IPO syndicate has waived and replaced the lock
-up undertakings by the relevant Executive Management Team members that were due
to expire on 14 May 2021. Following the transaction, the members of the
Executive Management Team participating in the transaction have undertaken a 6
-month extension of the lock-up agreement for their holdings after the
transaction, until 14 November 2021. T.D. Veen AS has undertaken a 3-month lock
-up agreement to 17 June 2021.

The following transactions are made by persons discharging managerial
responsibility or close associates thereto:

To facilitate settlement of the shares sold in the transaction, the non-selling
shareholder Stavanger Venture AS, controlled by board member Kjell Skappel, has
lent ABG Sundal Collier ASA 1,427,697 shares, which will be delivered back to
Stavanger Venture AS in full upon registration of the new shares in the Euronext
VPS.

Odd Sverre Østlie (CEO) has subscribed for 680,000 shares at an average
subscription price per share of NOK 28.44. He has himself and through Muzungu
Invest AS, which is controlled by Mr Østlie, sold 480,771 shares at NOK 100.00
per share. Prior to the event he and Muzungu Invest AS held 162,500 shares, and
after the transaction, Mr. Østlie will hold 361,729 shares and rights to 160,000
shares through himself and Muzungu Invest AS.

Øystein Hem (CFO) has subscribed for 180,000 shares at a subscription price per
share of NOK 38. He has sold 131,432 shares at NOK 100.00. Prior to the event he
held 17,500 shares, and after the transaction, Mr. Hem will hold 66,069 shares
and rights to 152,500 shares.

Nicolas Cormier (COO) has subscribed for 180,000 shares at an average
subscription price per

share of NOK 38. He has sold 159,202 shares at NOK 100.00. Prior to the event he
held 208,375 shares, and after the transaction, Mr. Cormier will hold 229,173
shares and rights to 60,000 shares.

Tom Erik Lia (CCO) has subscribed for 180,000 shares at an average subscription
price per

share of NOK 38. Mr Lia has himself and through Lia Investments Limited,
controlled by Mr Lia, sold 359,271 shares at NOK 100.00. Prior to the event he
and Lia Investments Limited held 1,583,523 shares, and after the transaction,
Mr. Lia will hold 1,404,252 shares and rights to 60,000 shares.

John Harald Grønningen (President EMEA) has subscribed for 180,000 shares at an
average subscription price per share of NOK 38. He has sold 175,562 shares at
NOK 100.00. Prior to the event he held 330,000 shares and after the transaction,
Mr. Grønningen will hold 334,438 shares and rights to 75,000 shares.

Karl Hantho (President Americas) has subscribed for 284,632 shares at an average
subscription price per share of NOK 30. He has sold 240,266 shares at NOK
100.00. Prior to the event he held 383,741 shares and after the transaction, Mr.
Hantho will hold 428,108 shares and rights to 60,000 shares.

Åsmund Fodstad (President APAC and Global Sales) has subscribed for 180,000
shares at an average subscription price per share of NOK 38. Mr. Fodstad has
himself and through Metrix Invest AS, controlled by Mr. Fodstad, sold 243,881
shares at NOK 100.00. Prior to the event he and Metrix Invest AS held 790,406
shares and after the transaction, Mr. Fodstad and Metrix Invest AS will hold
726,525 shares and rights to 60,000 shares.

TD Veen AS, where Kjell Skappel (Board member) is the CEO, has sold 784,009
shares at NOK 100.00 and will hold 4,604,764 shares after the transaction.

Following the issuance of the new shares, Pexip will have 103,817,383 shares
outstanding, each with a nominal value of NOK 0.015.

The information included in this announcement is such that the Company is
required to disclose in accordance with the EU Market Abuse Regulation (MAR),
and is publicly disclosed in accordance with MAR article 17 and section 5-12 of
the Norwegian Securities Trading Act. The announcement is made by the contact
person.

For further information, please contact:

Michel Sagen, Chair of the Board
+47 98 29 00 71
michel.sagen@pexip.com



Mirza Koristovic, IR Director
+47 93 87 05 25
ir@pexip.com

About Pexip | pexip.com

Pexip simplifies complex videoconferencing to empower organizations with face-to
-face collaboration, no matter the location or technology. Our scalable platform
enables high-quality video meetings, with enterprise-grade security, and is
easily adapted to fit customers' IT requirements and existing infrastructure.
This makes Pexip the leading provider for  large enterprises and public sector
organizations. The solution is sold through 300 channel partners in 75 countries
and used in more than 190 countries. Pexip was listed on the Oslo Børs in May
2020.